What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Thomas J. Giordano mostly deals with Cancer research, Gene, Adenocarcinoma, Gene expression profiling and Cancer.
His Cancer research research is multidisciplinary, incorporating elements of Cell, Somatic cell, Carcinogenesis, Tissue microarray and HRAS.
Gene is a subfield of Genetics that he tackles.
Thomas J. Giordano combines subjects such as Immunohistochemistry, Lung cancer, Pathology, Lung and Gene product with his study of Adenocarcinoma.
His Gene expression profiling research includes elements of DNA microarray, Microarray analysis techniques, Adrenocortical carcinoma and Human genome.
His research integrates issues of Mitotane, Immunology and Oncology in his study of Cancer.
His most cited work include:
- Somatic mutations affect key pathways in lung adenocarcinoma (2148 citations)
- Gene-expression profiles predict survival of patients with lung adenocarcinoma (1732 citations)
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma (1325 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cancer research, Pathology, Internal medicine, Cancer and Adenocarcinoma.
His Cancer research study incorporates themes from Cell culture, Gene expression, Gene, Immunology and Adrenocortical carcinoma.
His Gene study is related to the wider topic of Genetics.
His biological study spans a wide range of topics, including Thyroid carcinoma, Thyroid and Thyroid cancer.
His Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology.
Thomas J. Giordano focuses mostly in the field of Adenocarcinoma, narrowing it down to matters related to Molecular biology and, in some cases, Blot.
He most often published in these fields:
- Cancer research (41.29%)
- Pathology (35.61%)
- Internal medicine (24.62%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (41.29%)
- Internal medicine (24.62%)
- Gene (11.74%)
In recent papers he was focusing on the following fields of study:
Cancer research, Internal medicine, Gene, Somatic cell and Adrenocortical carcinoma are his primary areas of study.
The concepts of his Cancer research study are interwoven with issues in DNA methylation, Mutation, Phenotype, Pheochromocytoma and microRNA.
His Germline mutation study in the realm of Mutation connects with subjects such as Familial hyperaldosteronism.
His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Oncology and Histopathology.
His research investigates the connection between Oncology and topics such as Adenocarcinoma that intersect with issues in Noninvasive follicular thyroid neoplasm with papillary-like nuclear features, Thyroid neoplasm and Medical literature.
His Gene study integrates concerns from other disciplines, such as Protein kinase B and Signal transduction.
Between 2016 and 2021, his most popular works were:
- Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma (805 citations)
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (792 citations)
- Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma (264 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary areas of study are Cancer research, Gene, Somatic cell, Mutation and Internal medicine.
The various areas that Thomas J. Giordano examines in his Cancer research study include Germline mutation, Malignancy, DNA methylation, Germline and Pheochromocytoma.
His Gene research is multidisciplinary, incorporating elements of Transforming growth factor beta, Signal transduction and Protein kinase B.
His Mutation research incorporates elements of Hepatocellular carcinoma, microRNA, Thyroid and DNA sequencing.
As part of his studies on Internal medicine, Thomas J. Giordano frequently links adjacent subjects like Oncology.
His study focuses on the intersection of Oncology and fields such as Adenocarcinoma with connections in the field of Missense mutation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
